PepGen pauses Phase II DMD trial to review safety data

PepGen pauses Phase II DMD trial to review safety data

Submitted by admin on March 5, 2025 - 11:57am
Source: 
Clinical Trials Arena
News Tags: 
PepGen
FDA
PGN-EN051
clinical trials
DMD
Duchenne Muscular Dystrophy
Headline: 
PepGen pauses Phase II DMD trial to review safety data
snippet: 

PepGen has previously faced an FDA clinical hold on the investigational new drug application of PGN-ENO51 in the Phase II CONNECT2 trial.

Do Not Allow Advertisers to Use My Personal information